Clinical and immunological characteristics of type 1 diabetes mellitus in a northwestern Colombian population

We underwent a project aimed to define the clinical and immunological characteristics of type 1 diabetes (T1D) in a Colombian population. This was a multicenter and cross-sectional study. Patients were systematically interviewed and their medical records reviewed, using a questionnaire that sought i...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
2006
Institución:
Universidad del Rosario
Repositorio:
Repositorio EdocUR - U. Rosario
Idioma:
eng
OAI Identifier:
oai:repository.urosario.edu.co:10336/23849
Acceso en línea:
https://doi.org/10.1016/j.diabres.2005.10.016
https://repository.urosario.edu.co/handle/10336/23849
Palabra clave:
Antibody
Autoantibody
Glutamate decarboxylase antibody
Insulin antibody
Tyrosine phosphatase antibody
Unclassified drug
Adolescent
Adult
Article
Breast feeding
Child
Clinical feature
Colombia
Controlled study
Demography
Diabetic ketoacidosis
Disease duration
Ethnology
Female
Geography
Human
Immunology
Infant
Insulin dependent diabetes mellitus
Major clinical study
Male
Medical record
Onset age
Questionnaire
Radioimmunoassay
Sex difference
Adult
Age of onset
Autoantibodies
Colombia
Cross-sectional studies
Diabetic ketoacidosis
Female
Glutamate decarboxylase
Humans
Insulin antibodies
Male
Protein-tyrosine-phosphatase
Colombia
Gada
Ia-2a
Iaa
Type 1 diabetes
type 1
Diabetes mellitus
Rights
License
Abierto (Texto Completo)
Description
Summary:We underwent a project aimed to define the clinical and immunological characteristics of type 1 diabetes (T1D) in a Colombian population. This was a multicenter and cross-sectional study. Patients were systematically interviewed and their medical records reviewed, using a questionnaire that sought information about demographic, clinical and immunological characteristics. Glutamic acid decarboxylase antibodies (GADA), tyrosine phosphatase antibodies (IA-2A) and insulin antibodies (IAA) were examined by radioimmunoassay. There were 107 patients with T1D. Male:female ratio was 1:1. Half of the patients developed diabetes ketoacidosis at onset. GADA, IA-2A, and IAA were detected in 45%, 40%, and 69% of the cases, respectively. GADA positive patients were older and had a less duration of disease than patients without these autoantibodies (p less than 0.01). Association between breast feeding with the presence of antibodies or clinical characteristics was not observed. The results highlight some differences of T1D expression according to geographic location and ethnicity. Differences in age at onset and clinical variables may point to an environmental factor or deficient access to health care system. Genetic studies underway will provide important information in this population. These results might help to define public health policies in our population to improve T1D diagnosis, patients' quality of life and their outcome. © 2005 Elsevier Ireland Ltd. All rights reserved.